Evidence map›Paper›PMID 28542437›Full record

ArticlePloS one2017

CP5 system, for simple and highly efficient protein purification with a C-terminal designed mini tag.

Hiroyuki Takeda, Wei Zhou, Kohki Kido, Ryoji Suno, Takahiro Iwasaki, Takuya Kobayashi, Tatsuya Sawasaki

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. CF-PAScientific reports · 2019
    Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Hiroyuki TakedaProteo-Science Center, Ehime University, Matsuyama, Ehime, Japan.
Wei ZhouProteo-Science Center, Ehime University, Matsuyama, Ehime, Japan.
Kohki KidoProteo-Science Center, Ehime University, Matsuyama, Ehime, Japan.
Ryoji SunoDepartment of Medical Chemistry and Cell Biology, Kyoto University Graduate School of Medicine, Yoshida, Sakyo-ku, Kyoto, Japan.
Takahiro IwasakiProteo-Science Center, Ehime University, Matsuyama, Ehime, Japan.
Takuya KobayashiDepartment of Medical Chemistry and Cell Biology, Kyoto University Graduate School of Medicine, Yoshida, Sakyo-ku, Kyoto, Japan.
Tatsuya SawasakiProteo-Science Center, Ehime University, Matsuyama, Ehime, Japan.ORCID http://orcid.org/0000-0002-7952-0556
Ehime University · JPKyoto University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There are many strategies to purify recombinant proteins of interest, and affinity purification utilizing monoclonal antibody that targets a linear epitope sequence is one of the essential techniques used in current biochemistry and structural biology. Here we introduce a new protein purification system using a very short CP5 tag. First, we selected anti-dopamine receptor D1 (DRD1) rabbit monoclonal antibody clone Ra62 (Ra62 antibody) as capture antibody, and identified its minimal epitope sequence as a 5-amino-acid sequence at C-terminal of DRD1 (GQHPT-COOH, D1CE sequence). We found that single amino acid substitution in D1CE sequence (GQHVT-COOH) increased dissociation rate up to 10-fold, and named the designed epitope sequence CP5 tag. Using Ra62 antibody and 2 peptides with different affinity, we developed a new affinity protein purification method, CP5 system. Ra62 antibody quickly captures CP5-tagged target protein, and captured CP5-tagged protein was eluted by competing with higher affinity D1CE peptide. By taking the difference of the affinity between D1CE and CP5, sharp elution under mild condition was achieved. Using CP5 system, we successfully purified deubiquitinase CYLD and E3 ubiquitin ligase MARCH3, and detected their catalytic activity. As to G protein-coupled receptors (GPCRs), 9 out of 12 cell-free synthesized ones were purified, demonstrating its purification capability of integral membrane proteins. CP5 tagged CHRM2 expressed by baculovirus-insect cell was also successfully purified by CP5 system. CP5 system offers several distinct advantages in addition to its specificity and elution performance. CP5 tag is easy to construct and handle because of its short length, which has less effect on protein characters. Mild elution of CP5 system is particulaly suitable for preparing delicate proteins such as enzymes and membrane proteins. Our data demonstrate that CP5 system provides a new promising option in protein sample preparation with high yield, purity and activity for downstream applications in functional and structural analysis.

Indexed as

Amino Acid SubstitutionAnimalsAntibodies, MonoclonalCarrier ProteinsCell-Free SystemCHO CellsChromatography, AffinityCricetulusDeubiquitinating Enzyme CYLDEpitopesHEK293 CellsHeLa CellsHumansImmunoblottingMCF-7 CellsMembrane ProteinsAntibodies, MonoclonalCarrier ProteinsCYLD protein, humanDeubiquitinating Enzyme CYLDEpitopesMARCHF2 protein, humanMembrane ProteinsReceptors, Dopamine D1Recombinant ProteinsTumor Suppressor ProteinsUbiquitin-Protein Ligases

Identifiers

PMID28542437
PMCPMC5444806
OpenAlexW2617390969

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.